Tymlos (abaloparatide): what it treats, how to use it, side effects

Last updated September 3, 2026.

Tymlos (abaloparatide) is a daily self-injected bone-builder, a cousin of parathyroid hormone, for postmenopausal women with osteoporosis at high fracture risk. Like its older sibling Forteo (teriparatide), it is used for a maximum of 2 years in a lifetime, then hands off to an antiresorptive to keep what it built.

What does it treat?

Osteoporosis in postmenopausal women at high risk of fracture: prior fractures, very low bone density, or failure or intolerance of other osteoporosis drugs. In trials it cut new vertebral fractures dramatically over 18 months. It builds new bone rather than slowing its loss, which is why it is chosen for severe disease.

How do you take it?

One 80 mcg injection under the skin of the stomach area once daily, at the same time each day, rotating sites. The prefilled pen holds 30 doses; refrigerate it before first use, then it lives at room temperature for up to 30 days, then discard. The first few doses are taken sitting or lying down, because it can cause a brief blood-pressure dip with dizziness or racing heart right after injecting. Missed dose: take it that day when remembered; if the day has passed, skip it. Calcium and vitamin D repletion runs alongside.

Questions about Tymlos (abaloparatide)

Start a free AI doctor consult →

Side effects to know

Who should not take it?

Not with Paget's disease, prior skeletal radiation, bone cancers or metastases, or existing high blood calcium or hyperparathyroidism. It is not for children, not for men (approval is specific), and not in pregnancy. Kidney stones in your history raise the hypercalciuria caution. The 2-year lifetime limit counts across this drug and teriparatide together.

When is it an emergency?

Call 911 for fainting that does not resolve, severe palpitations with chest pain, or signs of a severe allergic reaction. Persistent nausea with confusion or extreme thirst can signal high calcium and needs prompt labs. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.

What a Pymander AI doctor consult looks like

What does your fracture history and DEXA say, and have you already tried a bisphosphonate?
T-score -3.4 at the spine, no fractures yet. I was on alendronate for 14 months and my density still dropped.
Thanks for giving me all this information. Based on what you've said, losing bone on a year-plus of alendronate with a -3.4 spine score is the textbook escalation case for an anabolic: build bone actively for up to 2 years, then lock it in with an antiresorptive again. The daily pen becomes routine fast, and the sit-down-for-the-first-doses rule is about the brief dizziness some people get. Here's your care note to share with your care team.
Care note
Bone loss on alendronate, anabolic escalation
T-score -3.4 spine, declining on 14 months of alendronate. Tymlos planned with 2-year cap and antiresorptive handoff; first-dose orthostasis teaching.
View care note →

Illustrative example, not a real member's messages.

Common questions

Why is there a lifetime 2-year limit?

Because rats given high doses long-term developed osteosarcoma, bone cancer. No such signal has emerged in humans, but the label caps cumulative use at 2 years out of caution, and that budget is shared with the sister drug teriparatide. Two years is also simply where the trial evidence ends.

How is Tymlos different from Forteo?

Siblings, not twins: Tymlos mimics PTH-related protein, Forteo mimics parathyroid hormone itself. Head-to-head data suggests slightly less hypercalcemia with Tymlos and comparable fracture protection. Both are daily pens, both cap at 2 years, and choice often comes down to insurance, cost, and which pen you prefer.

Why do the first doses make people dizzy?

A transient blood-vessel relaxation right after injection can drop blood pressure briefly: dizziness, racing heart, or nausea within about 4 hours of dosing. It fades with continued use. The standard advice is to inject sitting or lying down for the first several doses until you know your response.

What happens after my 2 years are up?

A scheduled handoff to an antiresorptive, typically a bisphosphonate or denosumab. The anabolic years build the bone; the antiresorptive years keep it from melting back. Stopping without the handoff is how patients lose a meaningful chunk of what they built within a year or two.

Does it interact with my calcium supplements?

It needs them, actually: calcium and vitamin D repletion runs alongside unless your blood calcium is high, in which case the drug waits. Regular checks of blood and urine calcium catch the minority who overshoot. The supplements are part of the program, not a conflict.

Is the daily injection hard to learn?

Most patients are independent within a week: the pen is prefilled for 30 days of doses, the needle is small, and the abdomen is an easy reach. After the first use the pen stays at room temperature for the month, no daily fridge trips. Clinic training on day one is standard.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult